Acadia Pharmaceuticals Inc
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,387 | 0.0% | 126,807 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,149 | 0.0% | 100,697 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 2,172 | 0.0% | 100,691 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,649 | 0.0% | 99,279 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,865 | 0.0% | 101,658 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,572 | 0.0% | 102,234 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 1,716 | 0.0% | 105,576 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 2,012 | 0.0% | 108,822 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 3,592 | 0.0% | 114,739 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 2,505 | 0.0% | 120,217 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 3,359 | 0.0% | 140,237 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 2,850 | 0.0% | 151,423 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 2,446 | 0.0% | 153,621 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 2,481 | 0.0% | 151,653 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 2,174 | 0.0% | 154,302 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 3,725 | 0.0% | 153,782 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 3,894 | 0.0% | 166,818 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 2,712 | 0.0% | 163,279 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 4,389 | 0.0% | 179,968 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 5,500 | 0.0% | 213,169 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 11,457 | 0.0% | 214,318 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 8,659 | 0.0% | 209,916 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 9,126 | 0.0% | 188,285 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 7,228 | 0.0% | 171,084 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 7,355 | 0.0% | 171,931 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 3,418 | 0.0% | 140,478 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 3,171 | 0.0% | 126,878 | 12/31/2013 |